Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database

  • 0Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. christopher.connors@icahn.mssm.edu.

|

|

Summary

This summary is machine-generated.

Upper urinary tract squamous cell carcinoma (UT-SCC) is a rare, aggressive cancer often diagnosed at advanced stages. Positive surgical margins are a key predictor of mortality, and surgery offers no survival benefit for metastatic UT-SCC.

Area Of Science

  • Urology
  • Oncology
  • Cancer Research

Background

  • Upper urinary tract squamous cell carcinoma (UT-SCC) is a rare malignancy.
  • Understanding its characteristics and outcomes is crucial for patient management.

Purpose Of The Study

  • To investigate the disease characteristics, treatment patterns, and survival outcomes of UT-SCC.
  • To compare UT-SCC with upper tract urothelial carcinoma (UTUC) using the National Cancer Database (NCDB).

Main Methods

  • The NCDB was queried for UT-SCC and UTUC patients (2004-2020).
  • Baseline characteristics were compared between UT-SCC and UTUC cohorts.
  • Kaplan-Meier analysis and multivariate Cox regression assessed survival and mortality predictors.

Main Results

  • 644 UT-SCC and 55,994 UTUC cases were identified.
  • UT-SCC presented with higher TNM stage, lymphovascular invasion, and positive surgical margins compared to UTUC.
  • UT-SCC showed poorer prognosis for carcinoma in situ and T3-T4 disease, with positive surgical margins and metastatic disease predicting mortality.

Conclusions

  • UT-SCC is a rare, aggressive cancer often diagnosed at a more advanced stage than UTUC.
  • Surgical margin status is a significant predictor of UT-SCC mortality.
  • Further research is needed to optimize treatment strategies for UT-SCC.